180 related articles for article (PubMed ID: 1379348)
1. [Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin].
Rondeau E
Nephrologie; 1992; 13(3):137. PubMed ID: 1379348
[No Abstract] [Full Text] [Related]
2. Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.
Bierer BE
Proc Assoc Am Physicians; 1995 Apr; 107(1):28-40. PubMed ID: 8630742
[No Abstract] [Full Text] [Related]
3. Modes of action of FK506, cyclosporin A, and rapamycin.
Morris R
Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
[No Abstract] [Full Text] [Related]
4. In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use.
Morris RE
Transplant Proc; 1991 Dec; 23(6):2722-4. PubMed ID: 1721257
[No Abstract] [Full Text] [Related]
5. Effect of immunosuppressive drugs (CsA, FK 506, rapamycin) on the kidney microsomal cytochrome P-450 system in the rat.
Yoshimura R; Yoshimura N; Ohmachi T; Nakatani T; Ohyama A; Miyao Y; Yamamoto K; Kishimoto T
Transplant Proc; 1994 Oct; 26(5):2890. PubMed ID: 7524223
[No Abstract] [Full Text] [Related]
6. FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line.
Wang SC; Zeevi A; Jordan ML; Simmons RL; Tweardy DJ
Transplant Proc; 1991 Dec; 23(6):2920-2. PubMed ID: 1721312
[No Abstract] [Full Text] [Related]
7. FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function.
Pelekanou V; Trezise AE; Moore AL; Kay JE
Transplant Proc; 1991 Dec; 23(6):3200-1. PubMed ID: 1721408
[No Abstract] [Full Text] [Related]
8. Comparative effects of rapamycin, FK 506 and cyclosporine on antibody production, lymphocyte populations and immunoglobulin isotype switching in the rat.
Thomson AW; Propper DJ; Woo J; Whiting PH; Milton JI; Macleod AM
Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):355-69. PubMed ID: 7693791
[TBL] [Abstract][Full Text] [Related]
9. Effects of the immunosuppressive macrolides rapamycin and FK 506 in high responder rats presensitized to major histocompatibility complex antigens.
Propper DJ; Woo J; Macleod AM; Catto GR; Thomson AW
Transplant Proc; 1993 Feb; 25(1 Pt 1):673-4. PubMed ID: 7679837
[No Abstract] [Full Text] [Related]
10. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
Bierer BE
Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
[No Abstract] [Full Text] [Related]
11. Osteoblastic differentiation is enhanced by rapamycin in rat osteoblast-like osteosarcoma (ROS 17/2.8) cells.
Ogawa T; Tokuda M; Tomizawa K; Matsui H; Itano T; Konishi R; Nagahata S; Hatase O
Biochem Biophys Res Commun; 1998 Aug; 249(1):226-30. PubMed ID: 9705862
[TBL] [Abstract][Full Text] [Related]
12. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia.
Sharkey J; Butcher SP
Nature; 1994 Sep; 371(6495):336-9. PubMed ID: 7522303
[TBL] [Abstract][Full Text] [Related]
13. FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
Bierer BE; Jin YJ; Fruman DA; Calvo V; Burakoff SJ
Transplant Proc; 1991 Dec; 23(6):2850-5. PubMed ID: 1721296
[No Abstract] [Full Text] [Related]
14. Categorizing receptor-signaling pathways with FK 506 and rapamycin.
Hultsch T; Hohman RJ
Transplant Proc; 1991 Dec; 23(6):2961-3. PubMed ID: 1721328
[No Abstract] [Full Text] [Related]
15. Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts.
Akselband Y; Harding MW; Nelson PA
Transplant Proc; 1991 Dec; 23(6):2833-6. PubMed ID: 1721292
[No Abstract] [Full Text] [Related]
16. The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivo.
Francavilla A; Starzl TE; Carr B; Azzarone A; Carrieri G; Zeng QH; Porter KA
Transplant Proc; 1991 Dec; 23(6):2817-20. PubMed ID: 1721287
[No Abstract] [Full Text] [Related]
17. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.
Zeevi A; Woan M; Yao GZ; Venkataramanan R; Todo S; Starzl TE; Duquesnoy RJ
Transplant Proc; 1991 Dec; 23(6):2928-30. PubMed ID: 1721315
[No Abstract] [Full Text] [Related]
18. Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect.
Cooper MH; Gregory SH; Thomson AW; Fung JJ; Starzl TE; Wing EJ
Transplant Proc; 1991 Dec; 23(6):2957-8. PubMed ID: 1721326
[No Abstract] [Full Text] [Related]
19. Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin.
Duncan JI
J Invest Dermatol; 1994 Jan; 102(1):84-8. PubMed ID: 7507155
[TBL] [Abstract][Full Text] [Related]
20. The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506.
Nakajima H; Oka T
Transplant Proc; 1996 Apr; 28(2):1052-5. PubMed ID: 8623224
[No Abstract] [Full Text] [Related]
[Next] [New Search]